Goldman Sachs Reiterates Neutral on Humana, Raises PT to $100

Goldman Sachs reiterated its Neutral rating on Humana HUM. At the same time, the rating agency raised its price target on the company's stock from $96 to $100. On Monday, Hum closed the day at $72.36. Its shares lost 0.15% of their value in today's pre-market trading to stand around $72.25.